Ajinomoto Buys California-Based CDMO Althea Technologies

Ajinomoto Co., Inc., said it has agreed to acquire Althea Technologies, Inc., a biopharmaceutical contract development and manufacturing organization. Ajinomoto said the acquisition is part of its efforts to expand into the biopharmaceutical industry. Expected to close in April 2013, the deal will make Althea, a fully integrated CDMO that provides fill and finish, biologics manufacturing, analytical development, and stability testing services for biopharmaceutical companies, into a fully consolidated subsidiary Ajinomoto.